Source:http://linkedlifedata.com/resource/pubmed/id/11054748
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2000-11-21
|
pubmed:abstractText |
Although the muscles of the mdx mouse lack dystrophin, the protein absent in muscles of humans affected with Duchenne muscular dystrophy (DMD), the only mdx muscle to degenerate in a manner similar to those of DMD boys is the diaphragm. We have previously shown that leukemia inhibitory factor (LIF) is a trauma factor that enhances muscle repair in vivo and, when applied exogenously, increases the fiber size of mdx skeletal muscle. Furthermore, we developed a controlled release device for LIF based on a calcium alginate rod (release rate about 0.5% per day). These rods were sutured to the abdominal surface of the hemidiaphragm of mdx mice 3 months old. At age 6 months the mice were killed and the diaphragm muscles fixed and sectioned. The sections showed obvious muscle degeneration at 3 months of age in mdx mouse diaphragms and further degeneration at 6 months in saline-perfused muscle. Hemidiaphragm muscles continuously exposed to LIF over the same period contained more normal myofibers, larger regenerated fibers, and less adipose tissue and other non-contractile tissue. Morphometric analysis of the diaphragm sections was carried out. The LIF-treated animals showed a significant increase in fiber number and size compared to saline rod controls. The amount of nonmuscle (connective tissue and adipose tissue) was significantly reduced and the maximum force-producing capacity of isolated diaphragm muscle strips was higher in LIF-treated mice. The results demonstrate that LIF treatment ameliorates the dystrophic abnormalities in mdx mouse diaphragm.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Growth Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Leukemia Inhibitory Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Lif protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0148-639X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 John Wiley & Sons, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1700-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11054748-Animals,
pubmed-meshheading:11054748-Cell Size,
pubmed-meshheading:11054748-Diaphragm,
pubmed-meshheading:11054748-Growth Inhibitors,
pubmed-meshheading:11054748-Infusion Pumps, Implantable,
pubmed-meshheading:11054748-Interleukin-6,
pubmed-meshheading:11054748-Leukemia Inhibitory Factor,
pubmed-meshheading:11054748-Lymphokines,
pubmed-meshheading:11054748-Mice,
pubmed-meshheading:11054748-Mice, Inbred C57BL,
pubmed-meshheading:11054748-Mice, Inbred mdx,
pubmed-meshheading:11054748-Muscle Contraction,
pubmed-meshheading:11054748-Muscle Fatigue,
pubmed-meshheading:11054748-Muscle Fibers, Skeletal,
pubmed-meshheading:11054748-Muscular Atrophy,
pubmed-meshheading:11054748-Muscular Dystrophy, Animal,
pubmed-meshheading:11054748-Recombinant Proteins
|
pubmed:year |
2000
|
pubmed:articleTitle |
Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse.
|
pubmed:affiliation |
Melbourne Neuromuscular Research Institute, St. Vincent's Hospital, Victoria Parade, Fitzroy, Victoria 3065, Australia. austinl@svhm.org.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|